Fresenius Medical Care AG... (FMS)
NYSE: FMS
· Real-Time Price · USD
24.87
0.03 (0.12%)
At close: Aug 14, 2025, 3:59 PM
24.98
0.44%
Pre-market: Aug 15, 2025, 08:54 AM EDT
Fresenius Medical Care & KGaA Income Statement
Financials in EUR. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 19.52B | 19.49B | 19.34B | 19.24B | 19.42B | 19.47B | 19.45B | 19.46B | 19.62B | 19.55B | 19.4B | 19.05B | 18.39B | 17.96B | 17.62B | 17.37B | 17.34B | 17.58B |
Cost of Revenue | 14.7B | 14.73B | 14.58B | 14.4B | 14.5B | 14.52B | 14.53B | 14.54B | 14.57B | 14.35B | 14.09B | 13.77B | 13.2B | 12.83B | 12.54B | 12.24B | 12.11B | 12.2B |
Gross Profit | 4.82B | 4.77B | 4.76B | 4.84B | 4.92B | 4.95B | 4.93B | 4.92B | 5.05B | 5.2B | 5.31B | 5.28B | 5.19B | 5.13B | 5.08B | 5.13B | 5.23B | 5.38B |
Operating Income | 1.48B | 1.48B | 1.36B | 1.54B | 1.41B | 1.34B | 1.38B | 824.12M | 971.53M | 955.42M | 1.04B | 1.61B | 1.64B | 1.73B | 1.85B | 1.87B | 1.99B | 2.22B |
Interest Income | 75.34M | 71.49M | 72.17M | 77.46M | 85.67M | 91.8M | 88.22M | 86.35M | 77.26M | 65.88M | 67.91M | 70.91M | 70.45M | 71.67M | 72.81M | 58.81M | 50.75M | 47.97M |
Pretax Income | 1.16B | 1.15B | 1.03B | 1.17B | 1.02B | 960.6M | 1.01B | 966.96M | 1.13B | 1.12B | 1.22B | 1.32B | 1.37B | 1.45B | 1.57B | 1.57B | 1.68B | 1.88B |
Net Income | 656.43M | 618.16M | 537.9M | 658.91M | 530.24M | 483.24M | 546.13M | 552.2M | 697.95M | 763.96M | 841.91M | 876.65M | 919.6M | 932.17M | 969.31M | 917.75M | 998.21M | 1.13B |
Selling & General & Admin | 3.14B | 3.12B | 3.14B | 3.15B | 3.19B | 3.19B | 3.2B | 3.31B | 3.5B | 3.7B | 3.79B | 3.65B | 3.39B | 3.26B | 3.1B | 3.18B | 3.16B | 3.07B |
Research & Development | 172.14M | 179.61M | 184.13M | 199.63M | 212.63M | 224.22M | 231.99M | 227.99M | 236.43M | 234.66M | 228.57M | 234.57M | 225.45M | 222.05M | 221.02M | 205.02M | 197.59M | 196.57M |
Other Expenses | 25.54M | -9.44M | -200.86M | -321.81M | -209M | -133M | 68.63M | 68.63M | 68.63M | 68.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.34B | 3.29B | 3.39B | 3.29B | 3.54B | 3.64B | 3.59B | 3.69B | 3.81B | 4B | 4.01B | 3.89B | 3.62B | 3.48B | 3.32B | 3.38B | 3.36B | 3.27B |
Interest Expense | 392.44M | 398.86M | 407M | 417.41M | 432.16M | 433.84M | 424.64M | 413.18M | 391.86M | 371.51M | 360.07M | 355.07M | 346.56M | 345.41M | 353.53M | 356.53M | 367.73M | 387.68M |
Selling & Marketing Expenses | 575.07M | 390.82M | 390.89M | 390.89M | 190.56M | 190.56M | 203.28M | 203.28M | 203.28M | 203.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 18.04B | 18.09B | 18.04B | 17.77B | 18.11B | 18.16B | 18.11B | 18.23B | 18.38B | 18.35B | 18.1B | 17.65B | 16.82B | 16.31B | 15.86B | 15.62B | 15.47B | 15.47B |
Income Tax Expense | 316.89M | 337.65M | 316.6M | 341.55M | 313.46M | 295.59M | 300.1M | 297.1M | 320.88M | 302.66M | 324.92M | 320.92M | 313.68M | 326.05M | 353.13M | 413.13M | 432.48M | 494.19M |
Shares Outstanding (Basic) | 586.83M | 586.83M | 608.17M | 586.83M | 586.83M | 591.33M | 587.27M | 586.83M | 586.83M | 595.6M | 586.83M | 590M | 588.56M | 586.01M | 586.37M | 587.19M | 585.83M | 585.76M |
Shares Outstanding (Diluted) | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.83M | 586.29M | 586.16M | 586M | 586.26M | 586.13M | 586.02M |
EPS (Basic) | 1.13 | 1.06 | 0.92 | 1.13 | 0.91 | 0.83 | 0.85 | 0.77 | 1.01 | 1.02 | 1.15 | 1.30 | 1.38 | 1.50 | 1.66 | 1.57 | 1.71 | 1.94 |
EPS (Diluted) | 1.13 | 1.06 | 0.92 | 1.13 | 0.91 | 0.83 | 0.85 | 0.77 | 1.01 | 1.02 | 1.15 | 1.30 | 1.38 | 1.50 | 1.66 | 1.57 | 1.71 | 1.94 |
EBITDA | 2.69B | 2.6B | 2.59B | 3.19B | 3.15B | 3.23B | 3.24B | 3.23B | 3.42B | 3.38B | 3.42B | 3.46B | 3.39B | 3.45B | 3.55B | 3.69B | 3.8B | 4.03B |
EBIT | 1.55B | 1.55B | 1.46B | 1.64B | 1.51B | 1.45B | 1.46B | 1.38B | 1.52B | 1.49B | 1.58B | 1.68B | 1.71B | 1.8B | 1.93B | 1.92B | 2.04B | 2.27B |
Depreciation & Amortization | 1.14B | 1.15B | 1.14B | 1.54B | 1.57B | 1.59B | 1.64B | 1.73B | 1.84B | 1.86B | 1.84B | 1.78B | 1.68B | 1.64B | 1.62B | 1.76B | 1.76B | 1.77B |